Richard Gaynor's most recent trade in Zai Lab Limited - ADR was a trade of 10,831 American Depositary Shares done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zai Lab Limited - ADR | Richard Brian Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 10,831 | 54,899 (0%) | 0% | 0 | American Depositary Shares | |
| Alkermes plc | Richard Brian Gaynor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2025 | 8,013 | 0 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Richard Brian Gaynor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2025 | 8,013 | 33,008 (0%) | 0% | - | Ordinary Shares | |
| Alkermes plc | Richard Brian Gaynor | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.61 per share. | 31 May 2025 | 1,924 | 31,084 (0%) | 0% | 30.6 | 58,894 | Ordinary Shares |
| Alkermes plc | Richard Brian Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 13,474 | 13,474 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Richard Brian Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 6,142 | 6,142 | - | - | Restricted Stock Unit Award | |
| Zai Lab Limited - ADR | Richard Brian Gaynor | Director | Sale of securities on an exchange or to another person at price $ 35.07 per share. | 05 Mar 2025 | 2,500 | 44,068 (0%) | 0% | 35.1 | 87,675 | American Depositary Shares |
| Zai Lab Limited - ADR | Richard B. Gaynor | Director | Sale of securities on an exchange or to another person at price $ 19.50 per share. | 03 Sep 2024 | 2,500 | 46,568 (0%) | 0% | 19.5 | 48,750 | American Depositary Shares |
| Alkermes plc | Richard B. Gaynor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2024 | 6,104 | 26,460 (0%) | 0% | - | Ordinary Shares | |
| Alkermes plc | Richard B. Gaynor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2024 | 6,104 | 0 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Richard B. Gaynor | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.10 per share. | 29 Jun 2024 | 1,465 | 24,995 (0%) | 0% | 24.1 | 35,307 | Ordinary Shares |
| Zai Lab Limited - ADR | Richard B. Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 21,253 | 49,068 (0%) | 0% | 0 | American Depositary Shares | |
| Alkermes plc | Richard B. Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 17,492 | 17,492 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Richard B. Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 8,013 | 8,013 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Richard B. Gaynor | Director | Other type of transaction at price $ 0.00 per share. | 31 May 2024 | 1,236 | 63,036 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Richard B. Gaynor | Director | Other type of transaction at price $ 0.00 per share. | 31 May 2024 | 313 | 15,990 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Richard B. Gaynor | Director | Other type of transaction at price $ 0.00 per share. | 31 May 2024 | 256 | 13,079 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Richard B. Gaynor | Director | Other type of transaction at price $ 0.00 per share. | 31 May 2024 | 254 | 12,986 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Richard B. Gaynor | Director | Other type of transaction at price $ 0.00 per share. | 31 May 2024 | 231 | 11,785 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Richard B. Gaynor | Director | Other type of transaction at price $ 0.00 per share. | 31 May 2024 | 230 | 11,739 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Richard B. Gaynor | Director | Other type of transaction at price $ 0.00 per share. | 31 May 2024 | 224 | 11,424 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Richard B. Gaynor | Director | Other type of transaction at price $ 0.00 per share. | 31 May 2024 | 119 | 6,104 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Richard B. Gaynor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 5,957 | 21,786 (0%) | 0% | - | Ordinary Shares | |
| Alkermes plc | Richard B. Gaynor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 5,957 | 0 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Richard B. Gaynor | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.88 per share. | 07 Jul 2023 | 1,430 | 20,356 (0%) | 0% | 29.9 | 42,728 | Ordinary Shares |
| Alkermes plc | Richard B. Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 12,732 | 12,732 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Richard B. Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 5,985 | 5,985 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Richard B. Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 11,554 | 11,554 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Richard B. Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 5,957 | 5,957 | - | - | Restricted Stock Unit Award | |
| Infinity Pharmaceuticals Inc. | Richard B. Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 45,000 | 45,000 | - | - | Stock Option(right to buy) | |
| Alkermes plc | Richard B. Gaynor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2022 | 7,585 | 16,524 (0%) | 0% | - | Ordinary Shares | |
| Alkermes plc | Richard B. Gaynor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2022 | 7,585 | 0 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Richard B. Gaynor | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.19 per share. | 14 Jun 2022 | 695 | 15,829 (0%) | 0% | 27.2 | 18,897 | Ordinary Shares |
| Infinity Pharmaceuticals Inc. | Richard Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Alkermes plc | Richard Gaynor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 6,104 | 6,104 (0%) | 0% | 0 | Ordinary Shares | |
| Alkermes plc | Richard Gaynor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 6,104 | 0 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Richard Gaynor | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.92 per share. | 20 May 2021 | 1,404 | 4,700 (0%) | 0% | 21.9 | 30,776 | Ordinary Shares |
| Alkermes plc | Richard Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2020 | 11,509 | 11,509 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Richard Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2020 | 5,578 | 5,578 | - | - | Restricted Stock Unit Award |